OK-432 therapy in the world

​

In Japan, 37 facilities from Hokkaido to Kagoshima have taken part in joint research, and the therapy is now in the process of getting permission of treatment under medical insurance from the Ministry of Health and Welfare.

In the rest of the world, OK-432 therapy has been tested at 92 facilities of 33 countries in Asia, Africa, Europe, Scandinavia, and North and South Americas.

This year, I made presentations on the therapy in El Paso and Iowa in the U.S., Merida in Mexico, Padova in Italy, Nijmegen in the Netherlands. I also made a conference presentation in Manchester, Great Britain.

Despite these efforts to make the world aware of the treatment, there are still many people who are not aware of such treatment developed in Japan.

When I visited Merida City in Yucatan Peninsula of Mexico, Mr. Nakai of the Mainichi Newspaper asked me “Why have you gone so far?”

My answer was:
“It is difficult to find a new treatment method to a disease. It is even harder to receive respect and approval of the new treatment method from others. There is a patient who needs my treatment by my therapy in the country across the Pacific Ocean. As a doctor and researcher of the new treatment, there is nothing more grateful to be of some help. What a blessing it is! I am willing to go anywhere as long as my knowledge and experience can be of any assistance.”

Recently I was invited by the Medical Society of Sweden to talk on OK-432 therapy at the Congress of the Scandinavian Association of Pediatric Surgeons in next May.